Novartis AG said in a securities filing last week that Korean prosecutors launched a criminal investigation into allegations that “Novartis Korea utilized medical journals to provide inappropriate economic benefits to healthcare professionals.”
Search Results for: label/Wright Medical – Page 3
Image courtesy of Biocompatibles Inc.A marketing executive who alleged in a whistleblower lawsuit that a medical device maker lied to the U.S. Food and Drug Administration (FDA) was awarded $5.1 million this week.
[…] Company received a letter from the SEC requesting information relating to any potential violations of the U.S. Foreign Corrupt Practices Act in connection with the sale of medical devices in an unspecified number of foreign countries, including Greece, Poland and Germany. The letter notes that the Company is a significant participant in the medical […]
Fresenius Medical Care AG said in a securities filing Tuesday that it has set aside €200 million ($245 million) for a potential FCPA resolution with the DOJ and SEC.
An ombudsman for the Financial Conduct Authority said the agency should apologize to a former Royal Bank of Scotland employee after it revealed his name during a whistleblower investigation in 2013.
U.K.-based medical device maker Smith & Nephew plc agreed to pay $22.2 million to settle Foreign Corrupt Practices Act offenses committed by its U.S. and German subsidiaries. The company admitted bribing government-employed doctors in Greece for more than a decade to win business.
[…] Dougall, 44, an ex-vice president of DePuy International Limited of Leeds, appeared Tuesday in the City of Westminster Magistrates’ Court. He’s accused of making corrupt payments to medical professionals in the Greek public healthcare system in order to sell orthopaedic products. The conduct allegedly occurred between February 2002 and December 2005. The summons charged […]
The World Bank announced the debarment of two China construction companies and a medical equipment supplier in Romania.
A medical device maker that misrepresented the amount of commissions it promised to pay a local agent in Bangladesh was one of three companies the World Bank debarred in separate actions announced Wednesday.